Profiles

Keywords
Last Name
Institution

Michael Liptay

Concepts (392)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
65
2021
753
8.910
Why?
Carcinoma, Non-Small-Cell Lung
47
2021
367
6.610
Why?
Pneumonectomy
26
2021
89
3.800
Why?
Sentinel Lymph Node Biopsy
9
2015
22
2.470
Why?
Lymph Nodes
9
2015
86
2.430
Why?
Neoplasm Staging
34
2021
516
1.780
Why?
Radiopharmaceuticals
7
2009
64
1.760
Why?
Thoracic Surgery, Video-Assisted
5
2015
22
1.240
Why?
Mesothelioma
6
2012
17
1.220
Why?
Adenocarcinoma
8
2014
235
1.190
Why?
Esophageal Neoplasms
4
2011
61
1.070
Why?
Humans
92
2021
30741
1.070
Why?
Lymphatic Metastasis
13
2015
111
1.040
Why?
Carcinoma, Squamous Cell
5
2019
198
1.030
Why?
Neoadjuvant Therapy
8
2015
70
1.010
Why?
Bronchoscopy
6
2019
38
1.000
Why?
Pleural Neoplasms
6
2012
13
0.940
Why?
Technetium Tc 99m Sulfur Colloid
4
2009
8
0.920
Why?
Postoperative Complications
11
2021
1084
0.870
Why?
Neoplasm Recurrence, Local
8
2017
230
0.860
Why?
Respiration, Artificial
1
2021
111
0.820
Why?
Aged
48
2021
10156
0.820
Why?
Small Cell Lung Carcinoma
1
2019
13
0.790
Why?
False Positive Reactions
1
2019
40
0.780
Why?
Unnecessary Procedures
1
2019
30
0.760
Why?
Male
55
2021
17552
0.740
Why?
Female
53
2021
18107
0.720
Why?
Prognosis
17
2017
1045
0.710
Why?
Mediastinal Neoplasms
2
2009
14
0.660
Why?
Middle Aged
44
2021
11256
0.630
Why?
Carcinoma, Bronchogenic
1
2015
14
0.620
Why?
Anastomosis, Surgical
2
2011
56
0.570
Why?
Gene Expression Regulation, Neoplastic
2
2016
135
0.560
Why?
Thoracic Surgery
6
2019
33
0.540
Why?
Mediastinitis
2
2009
7
0.500
Why?
Aged, 80 and over
22
2018
5172
0.490
Why?
Breast Neoplasms
2
2007
440
0.490
Why?
Treatment Outcome
21
2017
3850
0.480
Why?
Pulmonary Diffusing Capacity
3
2016
10
0.480
Why?
Solitary Pulmonary Nodule
3
2015
14
0.480
Why?
Mediastinal Diseases
1
2012
5
0.480
Why?
Histoplasmosis
1
2012
9
0.480
Why?
Esophagectomy
1
2011
25
0.470
Why?
Practice Management, Medical
1
2011
3
0.470
Why?
Chemoradiotherapy
6
2015
72
0.470
Why?
Survival Rate
11
2021
478
0.460
Why?
Adult
27
2017
9760
0.440
Why?
Airway Obstruction
2
2017
22
0.440
Why?
Xanthine Dehydrogenase
1
2010
7
0.430
Why?
Colon
1
2011
153
0.420
Why?
Carbon Monoxide
1
2009
5
0.420
Why?
Survival Analysis
11
2017
398
0.420
Why?
Aspergillus flavus
1
2009
5
0.410
Why?
Mediastinum
1
2009
8
0.410
Why?
Colorectal Neoplasms
2
2009
121
0.410
Why?
Aspergillosis
1
2009
14
0.410
Why?
Predictive Value of Tests
7
2014
631
0.400
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2015
421
0.390
Why?
Carcinoma, Neuroendocrine
1
2008
10
0.380
Why?
Carcinoid Tumor
1
2008
21
0.380
Why?
Gastrointestinal Stromal Tumors
1
2009
28
0.380
Why?
Risk Assessment
9
2019
804
0.380
Why?
Monitoring, Intraoperative
1
2009
41
0.380
Why?
Diagnosis, Differential
8
2018
469
0.370
Why?
Tomography, X-Ray Computed
9
2015
876
0.370
Why?
Neoplasms, Second Primary
1
2008
41
0.370
Why?
Retrospective Studies
16
2017
3456
0.370
Why?
Device Removal
2
2008
100
0.360
Why?
Catheterization
2
2007
64
0.360
Why?
Pleural Effusion, Malignant
1
2007
6
0.360
Why?
Neoplasms, Multiple Primary
2
2009
40
0.360
Why?
Diagnostic Imaging
1
2009
95
0.360
Why?
Preoperative Care
4
2015
149
0.350
Why?
Genital Neoplasms, Female
1
2007
14
0.350
Why?
Cohort Studies
10
2018
1959
0.350
Why?
Positron-Emission Tomography
1
2008
92
0.350
Why?
Early Detection of Cancer
4
2019
91
0.340
Why?
Combined Modality Therapy
8
2015
473
0.330
Why?
Multiple Pulmonary Nodules
2
2018
9
0.310
Why?
Follow-Up Studies
11
2021
2046
0.310
Why?
Multivariate Analysis
7
2017
391
0.310
Why?
Immunoassay
2
2018
44
0.300
Why?
Radionuclide Imaging
4
2009
58
0.290
Why?
Superior Vena Cava Syndrome
1
2003
8
0.270
Why?
Thoracoscopy
5
2019
19
0.270
Why?
Cesarean Section
1
2003
33
0.260
Why?
Disease-Free Survival
6
2017
247
0.260
Why?
Lymph Node Excision
4
2015
39
0.260
Why?
Insulin-Like Growth Factor Binding Proteins
2
2014
15
0.260
Why?
Thoracic Wall
2
2016
11
0.260
Why?
Lymphoma, Non-Hodgkin
1
2003
60
0.260
Why?
Technetium Compounds
1
2002
1
0.250
Why?
Tin Compounds
1
2002
1
0.250
Why?
Insulin-Like Growth Factor I
2
2014
60
0.250
Why?
Databases, Factual
7
2021
372
0.240
Why?
Lung
3
2021
169
0.240
Why?
Stents
2
2017
158
0.230
Why?
Registries
2
2021
203
0.230
Why?
Weight Gain
2
2012
68
0.220
Why?
Tidal Volume
1
2021
12
0.220
Why?
Biopsy
4
2012
286
0.220
Why?
Pneumonia
2
2019
75
0.210
Why?
Sensitivity and Specificity
4
2018
594
0.210
Why?
Kaplan-Meier Estimate
5
2012
230
0.210
Why?
Autoantibodies
2
2010
116
0.200
Why?
Esophagus
2
2011
59
0.200
Why?
Gases
1
2019
6
0.200
Why?
DNA Methylation
2
2012
165
0.200
Why?
Histiocytoma, Benign Fibrous
1
1999
5
0.200
Why?
Mediastinoscopy
1
2019
5
0.200
Why?
Algorithms
6
2014
421
0.200
Why?
Feasibility Studies
3
2009
283
0.190
Why?
Osteosarcoma
1
1999
42
0.190
Why?
History, 20th Century
2
2016
93
0.190
Why?
Intraoperative Period
3
2004
40
0.180
Why?
HLA Antigens
1
2018
21
0.180
Why?
Histocompatibility Antigens Class II
1
2018
17
0.180
Why?
Syndecan-1
1
2018
10
0.180
Why?
Histocompatibility Antigens Class I
1
2018
21
0.180
Why?
United States
5
2021
2467
0.180
Why?
Bone Neoplasms
1
1999
115
0.180
Why?
Neovascularization, Pathologic
2
2015
70
0.180
Why?
Tracheomalacia
1
2017
5
0.170
Why?
Tracheal Stenosis
1
2017
8
0.170
Why?
Nerve Growth Factors
1
2018
45
0.170
Why?
Silicones
1
2017
14
0.170
Why?
Mutagens
1
2016
2
0.170
Why?
Genomic Instability
1
2016
8
0.170
Why?
DNA Repair
1
2016
10
0.170
Why?
Sarcoma
2
2009
124
0.170
Why?
Ubiquitin-Protein Ligases
1
2016
46
0.160
Why?
Area Under Curve
3
2014
78
0.160
Why?
Ribs
1
2016
19
0.160
Why?
Risk Factors
7
2019
2611
0.160
Why?
Metformin
1
2016
21
0.160
Why?
Homeostasis
1
2016
106
0.160
Why?
Pulmonary Artery
2
1993
60
0.160
Why?
Proportional Hazards Models
3
2016
385
0.150
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2012
24
0.150
Why?
Cardiac Surgical Procedures
1
2016
98
0.150
Why?
Academic Medical Centers
1
2016
162
0.150
Why?
Hypoglycemic Agents
1
2016
76
0.150
Why?
Cardiology
1
2016
99
0.150
Why?
Lung Diseases, Fungal
1
2015
10
0.150
Why?
Mucormycosis
1
2015
7
0.150
Why?
Early Medical Intervention
1
2015
16
0.150
Why?
Heart Diseases
1
2016
102
0.150
Why?
Disease Progression
4
2014
851
0.150
Why?
Carcinoma
2
2015
84
0.150
Why?
Insulin-Like Growth Factor II
1
2014
10
0.140
Why?
Periodicals as Topic
1
2015
42
0.140
Why?
Clinical Trials as Topic
2
2012
386
0.140
Why?
Biopsy, Needle
2
2008
122
0.140
Why?
Cytokines
2
2014
348
0.140
Why?
Radiotherapy, Conformal
1
2014
24
0.140
Why?
Thoracotomy
5
2016
34
0.130
Why?
Social Class
1
2014
72
0.130
Why?
Radiotherapy, Adjuvant
5
2011
87
0.130
Why?
Arteriosclerosis
1
1993
22
0.130
Why?
Interleukin-2 Receptor alpha Subunit
1
2013
13
0.130
Why?
Genes, p16
1
2012
5
0.130
Why?
Diabetes Mellitus, Type 2
1
2016
222
0.130
Why?
Carcinoma, Small Cell
2
2010
86
0.130
Why?
Prosthesis Failure
1
2017
526
0.130
Why?
Extracellular Matrix
1
1993
90
0.120
Why?
Immunohistochemistry
3
2008
501
0.120
Why?
Prospective Studies
6
2021
1891
0.120
Why?
Esophageal Stenosis
1
2011
6
0.120
Why?
Macrophages
1
1993
114
0.120
Why?
Stomach
1
2011
19
0.120
Why?
Therapies, Investigational
1
2011
4
0.120
Why?
C-Peptide
1
2011
6
0.120
Why?
Forced Expiratory Volume
2
2009
12
0.120
Why?
Group Practice
1
2011
1
0.120
Why?
Appointments and Schedules
1
2011
15
0.120
Why?
Administrative Personnel
1
2011
9
0.120
Why?
Gene Expression
1
1993
271
0.120
Why?
Outpatient Clinics, Hospital
1
2011
14
0.120
Why?
Young Adult
4
2014
2249
0.110
Why?
Mentors
1
2011
38
0.110
Why?
Time Factors
4
2019
1911
0.110
Why?
Chemotherapy, Adjuvant
4
2011
114
0.110
Why?
Analysis of Variance
4
2015
369
0.110
Why?
Probability
2
2008
107
0.110
Why?
Chemoradiotherapy, Adjuvant
3
2015
21
0.110
Why?
Blood Chemical Analysis
1
2010
17
0.110
Why?
Length of Stay
6
2016
371
0.110
Why?
Hematologic Tests
1
2010
6
0.110
Why?
Protein Array Analysis
1
2010
11
0.110
Why?
Referral and Consultation
1
2011
93
0.110
Why?
PTEN Phosphohydrolase
1
2010
12
0.110
Why?
Apoptosis Regulatory Proteins
1
2010
20
0.110
Why?
Cell Line, Tumor
3
2018
296
0.110
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2010
28
0.100
Why?
Leadership
1
2011
100
0.100
Why?
Rhabdomyosarcoma
1
2009
7
0.100
Why?
Pleura
2
2007
7
0.100
Why?
Tumor Suppressor Proteins
1
2010
41
0.100
Why?
Antineoplastic Agents
4
2014
321
0.100
Why?
Adolescent
4
2010
2627
0.100
Why?
Models, Statistical
1
2010
146
0.100
Why?
Fibrosis
1
2009
57
0.100
Why?
Animals
5
2010
5221
0.100
Why?
Antifungal Agents
1
2009
42
0.100
Why?
Anti-Arrhythmia Agents
1
2010
105
0.100
Why?
Cause of Death
1
2009
74
0.100
Why?
Poland Syndrome
1
2009
1
0.100
Why?
Thoracoplasty
1
2009
1
0.100
Why?
Carcinoma, Large Cell
1
2009
18
0.100
Why?
Soft Tissue Neoplasms
1
2009
44
0.100
Why?
Smoking
1
2010
197
0.100
Why?
Silicone Elastomers
1
2008
3
0.090
Why?
Bronchial Fistula
1
2008
3
0.090
Why?
Esophageal Fistula
1
2008
3
0.090
Why?
Esophageal Perforation
1
2008
10
0.090
Why?
Surgical Wound Dehiscence
1
2008
12
0.090
Why?
Prosthesis Implantation
1
2008
43
0.090
Why?
Fluorodeoxyglucose F18
1
2008
35
0.090
Why?
Intraoperative Care
1
2008
58
0.090
Why?
Esophageal Achalasia
1
2007
22
0.090
Why?
Drainage
1
2007
55
0.090
Why?
Botulinum Toxins, Type A
1
2007
34
0.090
Why?
Age Factors
4
2014
941
0.090
Why?
Healthcare Disparities
1
2008
79
0.080
Why?
Incidence
3
2021
827
0.080
Why?
Atrial Fibrillation
1
2010
193
0.080
Why?
Neoplasm Invasiveness
2
2017
109
0.080
Why?
Delivery of Health Care
1
2008
115
0.080
Why?
Sepsis
1
2008
155
0.080
Why?
Radiotherapy Dosage
3
2015
147
0.080
Why?
Palliative Care
1
2007
136
0.080
Why?
Muscle, Skeletal
1
2009
374
0.070
Why?
Vinblastine
1
2004
15
0.070
Why?
Carboplatin
3
2011
52
0.070
Why?
Paclitaxel
3
2011
79
0.070
Why?
Deoxycytidine
1
2004
49
0.070
Why?
Radiography
2
2013
714
0.070
Why?
Societies, Medical
2
2019
203
0.070
Why?
Reoperation
1
2008
918
0.070
Why?
Patient Care Planning
1
2003
58
0.070
Why?
ROC Curve
2
2014
155
0.070
Why?
Magnetic Resonance Imaging
1
2009
1244
0.060
Why?
Hypertension, Pulmonary
2
1993
26
0.060
Why?
Illinois
2
2014
268
0.060
Why?
Heart Transplantation
2
1993
52
0.060
Why?
Tomography, Emission-Computed
2
1999
13
0.060
Why?
Graft Rejection
2
1993
85
0.060
Why?
Pregnancy
1
2003
452
0.060
Why?
Lung Diseases
2
1999
55
0.060
Why?
Radiography, Thoracic
2
2012
40
0.060
Why?
Etoposide
2
2011
64
0.050
Why?
Health Services Accessibility
2
2014
111
0.050
Why?
Chicago
2
2016
945
0.050
Why?
Sarcoma, Small Cell
1
1999
1
0.050
Why?
Aging
1
2010
1551
0.050
Why?
Anesthesia, Epidural
1
1999
29
0.050
Why?
Plasmacytoma
1
1999
19
0.050
Why?
Sarcoma, Ewing
1
1999
9
0.050
Why?
Electrocardiography
3
2003
231
0.050
Why?
Bupivacaine
1
1999
55
0.050
Why?
Pilot Projects
1
2000
440
0.050
Why?
Anesthetics, Local
1
1999
86
0.050
Why?
Radiation Injuries
1
1999
44
0.050
Why?
Case-Control Studies
2
2010
694
0.050
Why?
Postoperative Care
1
1999
142
0.050
Why?
Endoscopy
2
1997
177
0.040
Why?
Remission Induction
2
2010
127
0.040
Why?
Dilatation
1
2017
13
0.040
Why?
DNA End-Joining Repair
1
2016
1
0.040
Why?
Amino Acid Motifs
1
2016
20
0.040
Why?
Protein Transport
1
2016
42
0.040
Why?
DNA Damage
1
2016
33
0.040
Why?
Ubiquitin
1
2016
34
0.040
Why?
History, 21st Century
1
2016
41
0.040
Why?
Carcinogenesis
1
2016
24
0.040
Why?
History, 19th Century
1
2016
76
0.040
Why?
Procollagen
2
1993
10
0.040
Why?
Diffusion of Innovation
1
2016
42
0.040
Why?
Pneumonia, Bacterial
1
2016
15
0.040
Why?
Muscle, Smooth, Vascular
2
1993
28
0.040
Why?
Tracheostomy
1
2016
27
0.040
Why?
Education, Medical, Graduate
1
2016
82
0.040
Why?
Pain, Postoperative
1
1999
305
0.040
Why?
Neoplasm, Residual
1
2015
11
0.040
Why?
Phenotype
1
2016
368
0.040
Why?
Intubation, Intratracheal
1
2016
66
0.040
Why?
Minnesota
1
2014
12
0.040
Why?
Diabetes Mellitus
1
2016
140
0.040
Why?
Actuarial Analysis
1
2014
16
0.040
Why?
Induction Chemotherapy
1
2014
14
0.040
Why?
Academies and Institutes
1
2014
12
0.030
Why?
Cancer Care Facilities
1
2014
6
0.030
Why?
Arrhythmias, Cardiac
1
1996
169
0.030
Why?
Mutation
1
2016
457
0.030
Why?
Propensity Score
1
2014
54
0.030
Why?
Radiotherapy, Intensity-Modulated
1
2014
40
0.030
Why?
Internship and Residency
1
2016
187
0.030
Why?
Patient Readmission
1
2015
124
0.030
Why?
Chemokine CCL3
1
2013
12
0.030
Why?
Interleukin 1 Receptor Antagonist Protein
1
2013
15
0.030
Why?
Granuloma
1
2013
16
0.030
Why?
Signal Transduction
1
2016
582
0.030
Why?
Chemokine CXCL12
1
2013
9
0.030
Why?
Fibronectins
1
1993
32
0.030
Why?
Collagen
1
1993
111
0.030
Why?
Coronary Circulation
1
1993
49
0.030
Why?
Pulmonary Circulation
1
1992
7
0.030
Why?
Respiratory Mechanics
1
1992
10
0.030
Why?
Reperfusion Injury
1
1992
9
0.030
Why?
Interleukin-10
1
2013
42
0.030
Why?
Respiratory Tract Infections
1
2013
53
0.030
Why?
Ischemia
1
1992
32
0.030
Why?
Logistic Models
1
2014
479
0.030
Why?
Telemetry
1
1992
15
0.030
Why?
Interleukin-6
1
2013
120
0.030
Why?
Decision Support Techniques
1
2012
54
0.030
Why?
Epigenesis, Genetic
1
2012
91
0.030
Why?
Prevalence
1
2014
546
0.030
Why?
Tumor Necrosis Factor-alpha
1
2013
228
0.030
Why?
Digestive System Surgical Procedures
1
2011
27
0.030
Why?
Reproducibility of Results
1
2014
875
0.030
Why?
Medical Oncology
1
2011
39
0.030
Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
10
0.030
Why?
Choice Behavior
1
2011
62
0.030
Why?
Serum
1
2010
8
0.030
Why?
Tandem Mass Spectrometry
1
2010
23
0.030
Why?
Antibodies, Neoplasm
1
2010
18
0.030
Why?
Monomeric GTP-Binding Proteins
1
2010
4
0.030
Why?
Death-Associated Protein Kinases
1
2010
5
0.030
Why?
DNA Modification Methylases
1
2010
6
0.030
Why?
DNA Repair Enzymes
1
2010
9
0.030
Why?
Antigens, Neoplasm
1
2010
56
0.030
Why?
Immunoenzyme Techniques
1
2010
55
0.030
Why?
In Situ Hybridization, Fluorescence
1
2010
43
0.030
Why?
Cadherins
1
2010
37
0.030
Why?
CpG Islands
1
2010
52
0.030
Why?
Medical Records
1
2010
40
0.030
Why?
Neoplasm Proteins
1
2010
61
0.030
Why?
Promoter Regions, Genetic
1
2010
106
0.030
Why?
Proteomics
1
2010
62
0.030
Why?
Antigens, CD
1
2010
107
0.030
Why?
Fluorouracil
1
2009
89
0.030
Why?
Adaptor Proteins, Signal Transducing
1
2010
93
0.020
Why?
Cisplatin
1
2009
107
0.020
Why?
Carcinoma, Renal Cell
1
2009
77
0.020
Why?
Kidney Neoplasms
1
2009
110
0.020
Why?
Surgical Flaps
1
2009
54
0.020
Why?
Sutures
1
2008
43
0.020
Why?
Dogs
3
1993
286
0.020
Why?
Esophageal Diseases
1
2007
7
0.020
Why?
Ulcer
1
2007
7
0.020
Why?
Video Recording
2
1997
49
0.020
Why?
Maximum Tolerated Dose
1
2004
22
0.020
Why?
Statistics, Nonparametric
1
2004
162
0.020
Why?
Drug Administration Schedule
1
2004
271
0.020
Why?
Respiratory Function Tests
1
2003
35
0.020
Why?
Dose-Response Relationship, Drug
1
2004
527
0.020
Why?
Weight Loss
1
2003
107
0.020
Why?
Transplantation, Heterotopic
2
1993
13
0.020
Why?
Health Status
1
2003
252
0.010
Why?
African Americans
1
2008
780
0.010
Why?
Vital Capacity
1
1999
8
0.010
Why?
Pruritus
1
1999
17
0.010
Why?
Fentanyl
1
1999
23
0.010
Why?
Urinary Retention
1
1999
12
0.010
Why?
Cardiovascular Diseases
1
2003
391
0.010
Why?
Narcotics
1
1999
33
0.010
Why?
Thoracic Neoplasms
1
1997
9
0.010
Why?
Abdominal Neoplasms
1
1997
13
0.010
Why?
Pericardial Window Techniques
1
1996
3
0.010
Why?
Pain Measurement
1
1999
475
0.010
Why?
Treatment Failure
1
1997
188
0.010
Why?
Morbidity
1
1996
71
0.010
Why?
Radiotherapy
1
1995
68
0.010
Why?
Neoplasm Metastasis
1
1995
148
0.010
Why?
Recurrence
1
1995
390
0.010
Why?
Desmin
1
1993
2
0.010
Why?
Staining and Labeling
1
1993
27
0.010
Why?
Actins
1
1993
62
0.010
Why?
Cyclosporine
1
1993
19
0.010
Why?
Acid-Base Equilibrium
1
1992
5
0.010
Why?
Blood Gas Analysis
1
1992
11
0.010
Why?
Pulmonary Alveoli
1
1992
24
0.010
Why?
Capillary Permeability
1
1992
28
0.010
Why?
Body Temperature
1
1992
74
0.010
Why?
Hemodynamics
1
1992
106
0.010
Why?
Reactive Oxygen Species
1
1992
127
0.010
Why?
Electrodes, Implanted
1
1992
49
0.010
Why?
Antibodies, Monoclonal
1
1993
311
0.010
Why?
Monitoring, Physiologic
1
1992
101
0.010
Why?
Immunosuppressive Agents
1
1992
167
0.010
Why?
Myocardium
1
1992
180
0.010
Why?
Liptay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_